CD47 and breast carcinoma: To further examine the relationship between UPR signaling and CD47, we used the KM-plot data base (kmplot.com) and mined the breast cancer dataset to assess whether co-expression of GRP78 and CD47 impact the relapse-free survival (RFS) of breast cancer patients [10].